We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

82 hedge funds and large institutions have $272M invested in Albireo Pharma Inc in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

295% more call options, than puts

Call options by funds: $4.75M | Put options by funds: $1.2M

79% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 19

57% more capital invested

Capital invested by funds: $173M → $272M (+$98.7M)

19% more funds holding

Funds holding: 69 → 82 (+13)

Holders
82
Holders Change
+13
Holders Change %
+18.84%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
19
Closed
4
Calls
$4.75M
Puts
$1.2M
Net Calls
+$3.54M
Net Calls Change
+$930K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.32M
2
Marshall Wace
Marshall Wace
United Kingdom
+$2M
3
Deutsche Bank
Deutsche Bank
Germany
+$1.4M
4
SCM
Suvretta Capital Management
New York
+$752K
5
DCM
Driehaus Capital Management
Illinois
+$708K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.02M
2
Victory Capital Management
Victory Capital Management
Texas
-$5.9M
3
PM
Prosight Management
Texas
-$3.1M
4
AG
Artal Group
Luxembourg
-$2.07M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFGIA
76
Patriot Financial Group Insurance Agency
Massachusetts
$1K – – –
TFO
77
Tarbox Family Office
California
$1K – – –
S
78
SignatureFD
Georgia
$1K +$778 +33 New
KHCM
79
Kettle Hill Capital Management
New York
– -$414K -25,268 Closed
GCP
80
GSA Capital Partners
United Kingdom
– -$226K -13,787 Closed
MAM
81
Meeder Asset Management
Ohio
– -$11K -689 Closed
CCA
82
Column Capital Advisors
Indiana
– -$3K -186 Closed
EI
83
Ellevest Inc
New York
– +$118 +5 +500%
PAG
84
Private Advisor Group
New Jersey
– +$283 +12 New
GT
85
Glenmede Trust
Pennsylvania
– +$590 +25 New
1 2 3
4

ALBO Hedge Fund Activity: Q2 2020 in Review

82 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2020, worth a combined $272M — up 57% from $173M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ALBO positions and 4 closed out — a net gain of 13 holders — while 34 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock, adding an estimated $3.32M. The largest seller was Point72 Asset Management, cutting an estimated $8.02M.

  • 82 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2020, up from 69 in Q1 2020.
  • Funds reported $272M of Albireo Pharma Inc stock for Q2 2020, up 57% quarter-over-quarter.
  • 17 funds opened new Albireo Pharma Inc positions in Q2 2020 and 4 closed out, a net change of +13 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2020 was BlackRock, an estimated $3.32M added.
  • The largest Albireo Pharma Inc seller in Q2 2020 was Point72 Asset Management, an estimated $8.02M sold.

Based on aggregated 13F filings for Q2 2020.